AMBER GASKINS: Open Payments
NPI 1134557218 · LOUISVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,178 in 60 payments from 17 companies in 2025. Trend: 2023 $1,725 · 2024 $1,465 · 2025 $1,178
Food & beverage: $1,178
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $224 |
| Lilly USA, LLC | 8 | $155 |
| E.R. Squibb & Sons, L.L.C. | 8 | $137 |
| GlaxoSmithKline, LLC. | 5 | $89 |
| Inspire Medical Systems, Inc. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $73 |
| PFIZER INC. | 3 | $56 |
| SANOFI-AVENTIS U.S. LLC | 2 | $49 |
| Novartis Pharmaceuticals Corporation | 2 | $47 |
| Xeris Pharmaceuticals, Inc. | 2 | $41 |
Products named: Ozempic, JARDIANCE, CAMZYOS, TRELEGY ELLIPTA, INSPIRE, CAPLYTA, MOUNJARO, Rybelsus.
Industry payments across TN — which companies pay providers there.
